BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8914799)

  • 21. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
    Morris JC; Wildner O
    Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenoviral strategies for the gene therapy of cancer.
    Relph KL; Harrington KJ; Pandha H
    Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
    Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B
    Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering ex vivo-expanded marrow stromal cells to secrete calcitonin gene-related peptide using adenoviral vector.
    Deng W; Bivalacqua TJ; Chattergoon NN; Jeter JR; Kadowitz PJ
    Stem Cells; 2004; 22(7):1279-91. PubMed ID: 15579646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapeutic strategies for neurodegenerative diseases.
    Baekelandt V; De Strooper B; Nuttin B; Debyser Z
    Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
    Kuhlmann KF; van Geer MA; Bakker CT; Dekker JE; Havenga MJ; Elferink RP; Gouma DJ; Bosma PJ; Wesseling JG
    Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury.
    Abe K
    J Cereb Blood Flow Metab; 2000 Oct; 20(10):1393-408. PubMed ID: 11043902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications.
    Parker AL; Nicklin SA; Baker AH
    Curr Opin Mol Ther; 2008 Oct; 10(5):439-48. PubMed ID: 18830919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gene therapy of rat prolactinomas mediated by adenoviral vectors with rat tyrosine hydroxylase gene].
    Xu ZQ; Su CB; Chen SS; Ren ZY; Di X; Ma WB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):185-9. PubMed ID: 12905717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoter.
    Navarro V; Millecamps S; Geoffroy MC; Robert JJ; Valin A; Mallet J; Gal La Salle GL
    Gene Ther; 1999 Nov; 6(11):1884-92. PubMed ID: 10602384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vectors--shuttle vehicles for gene therapy.
    Wilson JM
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():31-2. PubMed ID: 9020933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances towards targetable adenovirus vectors for gene therapy.
    Einfeld DA; Roelvink PW
    Curr Opin Mol Ther; 2002 Oct; 4(5):444-51. PubMed ID: 12435045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons.
    Huang D; Desbois A; Hou ST
    Gene Ther; 2005 Sep; 12(18):1369-76. PubMed ID: 15843806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and application of adenoviral vectors for gene therapy of cancer.
    Zhang WW
    Cancer Gene Ther; 1999; 6(2):113-38. PubMed ID: 10195879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
    Kim J; Cho JY; Kim JH; Jung KC; Yun CO
    Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-hepatocarcinoma effect of recombinant adenovirus carrying melittin gene].
    Ling CQ; Li B; Zhang C; Gu W; Li SX; Huang XQ; Zhang YN
    Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):741-4. PubMed ID: 15619342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenoviral vectors--how to use them in cancer gene therapy?
    Majhen D; Ambriović-Ristov A
    Virus Res; 2006 Aug; 119(2):121-33. PubMed ID: 16533542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gene therapy of neurologic diseases. Experimental approaches and clinical perspectives].
    Isenmann S; Bähr M; Dichgans J
    Nervenarzt; 1996 Feb; 67(2):91-108. PubMed ID: 8851291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies for the development of cell lines for ex vivo gene therapy in the central nervous system.
    Mejía-Toiber J; Castillo CG; Giordano M
    Cell Transplant; 2011; 20(7):983-1001. PubMed ID: 21176399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.